Superbug yeast Candida auris (C. Auris) is an emerging fungus (yeast) that presents a serious global health threat. It is often multidrug-resistant (MDR), meaning that it is resistant to multiple antifungal drugs commonly used to treat Candida infections, making infections with C. Auris difficult to treat.
The posts in this series, document the current and growing, multi drug resistant (MDR) antibiotic resistant superbug global crisis.
Silver iontophoresis stimulator (SIS) technology can provide an effective solution for most MDR superbug infections, and is ready for immediate implementation. The SIS machine electro-stimulator and SIS silver-nylon electrode treatment system can be applied for the treatment of both surface and internal MDR superbug infections anywhere in the body.
Superbug report reveals rise in antibiotic-resistant gonorrhoea.
Antibiotic resistant superbugs near a ‘tipping point’.
Australia needs a new coordinating body to oversee work to slow the spread of superbugs and antibiotic resistance, infectious diseases experts say.
Methicillin-resistant Staphylococcus aureus (MRSA) superbug skin infections treated successfully with SIS machine M200 model.